title: Formononetin prevents ovariectomy-induced bone loss in rats.
abstract: The major risk factor of postmenopausal osteoporosis is estrogen deficiency. Hormone replacement therapy is efficacious against osteoporosis, but it induces several significant adverse effects. In this study, therefore, we compared therapeutic potencies of three phytoestrogens: genistein, daidzein, and formononetin. Our result showed that in Saos-2 cells, formononetin and genistein (5 x 10(-7) M) treatment increased alkaline phosphatase activity by 33.0 +/- 5.8% and 21.1 +/- 4.0%. Genistein inhibited osteoclast formation in a dose-dependent manner. In OVX rats, formononetin-treated groups given 1 and 10 mg/kg/day displayed increased trabecular bone areas (TBAs) within the tibia. Genistein- and daidzein-treated groups also displayed increased tibial TBAs. TBAs of the lumbar vertebrae were higher in all treated groups than in the control group. In conclusion, formononetin as well as other isoflavones, such as daidzein and genistein, inhibited bone loss caused by estrogen-deficiency.
authors.affiliation: Herbal Medicine EBM Research Center, Korea Institute of Oriental Medicine, Daejeon, 305-811, Korea.
authors.forename: Hyekyung
authors.initials: H
authors.lastname: Ha
authors.forename: Ho Young
authors.initials: HY
authors.lastname: Lee
authors.forename: Je-Hyun
authors.initials: JH
authors.lastname: Lee
authors.forename: Dayoung
authors.initials: D
authors.lastname: Jung
authors.forename: Jiyoon
authors.initials: J
authors.lastname: Choi
authors.forename: Kye-Yong
authors.initials: KY
authors.lastname: Song
authors.forename: Hee Jin
authors.initials: HJ
authors.lastname: Jung
authors.forename: Jae Sue
authors.initials: JS
authors.lastname: Choi
authors.forename: Soo-Ik
authors.initials: SI
authors.lastname: Chang
authors.forename: Chungsook
authors.initials: C
authors.lastname: Kim
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001862:Bone Resorption / Q000473:pathology / Q000517:prevention & control*; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D020128:Inhibitory Concentration 50; D007529:Isoflavones / Q000302:isolation & purification / Q000627:therapeutic use*; D051379:Mice; D010006:Osteoblasts / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010010:Osteoclasts / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010052:Ovariectomy; D018517:Plant Roots / Q000737:chemistry; D051381:Rats; D017207:Rats, Sprague-Dawley; D011960:Receptors, Estrogen / Q000378:metabolism; D029909:Sophora / Q000737:chemistry
chemical_list: D007529:Isoflavones; D011960:Receptors, Estrogen; C007768:formononetin; D000469:Alkaline Phosphatase